SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cresco Labs Inc. (CRLBF) , 前瞻盈利收益率 2.56%.
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+464.1%).
- 前瞻市盈率 39.0
- 分析师共识目标价 $5.50 (+464.1% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 38/100 其中 2/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
33/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CRLBF
估值倍数
P/E (TTM)0.0
前瞻 P/E39.0
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.50
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.42
前瞻 EPS（预估）$0.03
每股账面价值$0.00
每股营收$1.96
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield2.56%
股息收益率0.00%
分析师目标价$5.50 (+464.1%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-3.10 |
$0.00 |
$-108.59K |
- |
| 2017 |
$-2.63 |
$10.31M |
$-85.83K |
-0.8% |
| 2018 |
$-0.03 |
$43.25M |
$-1.92M |
-4.4% |
| 2019 |
$-0.37 |
$128.53M |
$-43.2M |
-33.6% |
| 2020 |
$-0.49 |
$476.25M |
$-102.16M |
-21.5% |
| 2021 |
$-1.22 |
$821.68M |
$-319.6M |
-38.9% |
| 2022 |
$-0.71 |
$842.68M |
$-212.05M |
-25.2% |
| 2023 |
$-0.54 |
$770.89M |
$-175.52M |
-22.8% |
| 2024 |
$-0.22 |
$724.34M |
$-74.44M |
-10.3% |
| 2025 |
$-0.42 |
$667.33M |
$-142.5M |
-21.4% |
